CVR number 25884132
Industry 64.3040 Trusts, funds and similar financial entities

P/S SUNSTONE BIOMEDICINSK VENTURE III

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Bankruptcy risk for industry  0.3% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 15.2% 11.4% 13.1% 28.9%  
Credit score (0-100)  0 16 23 19 3  
Credit rating  N/A BB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Net sales  0 0 0 0 0  
Gross profit  0.0 -5,494 -429 -822 -450  
EBITDA  0.0 -5,494 -429 -822 -450  
EBIT  0.0 -5,494 -429 -822 -450  
Pre-tax profit (PTP)  0.0 -17,085.0 957.0 3,067.0 -14,396.0  
Net earnings  0.0 -17,085.0 957.0 3,067.0 -14,396.0  
Pre-tax profit without non-rec. items  0.0 -17,085 957 3,067 -14,396  
 
See the entire income statement

Balance sheet (kDKK) 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 24,877 22,414 18,302 73.0  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 24,903 22,436 18,327 97.0  
Net Debt  0.0 -101 -42.0 -124 -97.0  
 
See the entire balance sheet

Volume 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -5,494 -429 -822 -450  
Gross profit growth  0.0% 0.0% 92.2% -91.6% 45.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 24,903 22,436 18,327 97  
Balance sheet change%  0.0% 0.0% -9.9% -18.3% -99.5%  
Added value  0.0 -5,494.0 -429.0 -822.0 -450.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -68.6% 4.1% 15.1% -156.2%  
ROI %  0.0% -68.6% 4.1% 15.1% -156.7%  
ROE %  0.0% -68.7% 4.0% 15.1% -156.7%  

Solidity 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Equity ratio %  0.0% 99.9% 99.9% 99.9% 75.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 1.8% 9.8% 15.1% 21.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Quick Ratio  0.0 957.8 1,019.8 733.1 4.0  
Current Ratio  0.0 957.8 1,019.8 733.1 4.0  
Cash and cash equivalent  0.0 101.0 42.0 124.0 97.0  

Capital use efficiency 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 24,877.0 22,414.0 18,302.0 73.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0